📰 Anges Inc News
Page 4 - Anges Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anges Inc. Real-time updates on events, politics, business and more.
September 19, 2022
Global Degenerative Disc Disease Market 2022-2026 The analyst has been monitoring the degenerative disc disease market and it is poised to grow by $ 1. 03...
August 12, 2022
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Gene Therapy Market by Vectors (Non-viral(Oligonucleotides), Viral(Retroviral, Adeno-associated)),...
August 11, 2022
/PRNewswire/ -- The "Global Gene Therapy Market by Vectors (Non-viral(Oligonucleotides), Viral(Retroviral, Adeno-associated)), Indication (Cancer,...
August 4, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
June 7, 2022
/PRNewswire/ -- DelveInsights critical limb ischemia market insights report includes a comprehensive understanding of current treatment practices, emerging...
June 7, 2022
The critical limb ischemia market is expected to expand with a rise in prevalence and the expected entry of emerging therapies into the 7MM markets. LAS VEGAS, June 7, 2022 /PRNewswire/
May 21, 2022
A Comprehensive Study Exploring Viral Gene Therapy Market | Key Players Spark Therapeutics, Gilead Sciences, Human Stem Cells Institute
May 21, 2022
A Comprehensive Study Exploring Viral Gene Therapy Market | Key Players Spark Therapeutics, Gilead Sciences, Human Stem Cells Institute
May 10, 2022
/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...
May 10, 2022
PALO ALTO, Calif. and OSAKA, Japan, May 10, 2022 /PRNewswire/ -- Eiger Biopharmaceuticals Inc. and AnGes Inc. today announced that the companies entered into an agreement for the regulatory...